No Prescription |
 |
 | ||
|
Marvelon Desogestrel Ethinyl Oestradiol |
|
| ||
No Prescription » Prescription Drugs 10 » Marvelon Desogestrel Ethinyl Oestradiol Oral Contraceptive Buy Marvelon Desogestrel Ethinyl Oestradiol and other Prescription Drugs 10 products online at Medstore. 177
About Marvelon Desogestrel Ethinyl Oestradiol: Product Type: Prescription Drugs 10 Marvelon (Desogestrel & Ethinyl Oestradiol) Marvelon (Desogestrel & Ethinyl Oestradiol) Desogestrel & Ethinyl Oestradiol 28's 84 tabs Desogestrel & Ethinyl Oestradiol Marvelon
View more Prescription Drugs 10 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
